Lataa...

Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum

Pemetrexed combined with platinum is a first-line therapy used to treat patients with advanced non-small cell lung cancer (NSCLC) that exhibit negative or unknown epidermal growth factor receptor (EGFR) mutational status or anaplastic lymphoma kinase (ALK) rearrangements. Lung adenocarcinoma (LAC) i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Zhu, Jinghua, Qi, Yuhua, Wu, Jianzhong, Shi, Meiqi, Feng, Jifeng, Chen, Longbang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2016
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228282/
https://ncbi.nlm.nih.gov/pubmed/28101226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5295
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!